Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in SARS CoV 2 virus

What Happens When The COVID-19 Vaccines Enter The Body – A Road Map For Kids And Grown-Ups

The Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines all work similarly by giving the body’s cells the instructions to make the spike protein.

Read More

COVID-19 Most Transmissible 2 Days Before, 3 Days After Symptoms Appear: Study

The researchers conducted contact tracing and studied COVID-19 transmission among approximately 9,000 close contacts of primary cases in the Zhejiang province of China from January 2020 to August 2020.

Read More

COVID-19 May Become A Mostly Childhood Disease In Few Years: Study

The US-Norwegian team noted that because COVID-19 severity is generally lower among children, the overall burden from this disease is expected to decline as the SARS-CoV-2 virus becomes endemic in the global population.

Read More

Covid-19 Herd Immunity? It's Not Going To Happen, So What Next For The World?

Peddling the concept of herd immunity creates a misconception that we are actually going to get to a stage where this virus is going to be eliminated.

Read More

Biocon Biologics Gets Licence From Adagio Therapeutics For Antibody Treatment Of COVID-19

Initial data indicate that ADG20 could provide both rapid and durable protection against COVID-19 for up to one year

Read More

Covid-19 Virus Highly Adapted To Infect Human Cells, Reveals Study

These models were then used to calculate the strength of binding of the SARS-CoV-2 spike protein to each species' ACE2, which acts as the receptor for SARS-CoV-2 and allows it to infect the cell.

Read More

Indus Health Plus Survey Reveals That Lifestyle Diseases Impact Productive Years Of Peoples’ Lives

The trend report highlights that females are prone to Anemia (23%), Dyslipidemia (20%) as compared to males. Males are at higher risk of diabetes (27%), Vitamin B12 deficiency (21%)and heart ailments (14%).

Read More

Unpredictable How Protective Vaccines Will Be Against New Covid Strains But Till Date Safe Against Outbreak: AIIMS Professor Neeraj Nischal

The enigma of incredibly complex Covid19 is still perplexing the science of medicine with severe mutations of SARS-CoV2 virus. This surge was expected as seen during the last major Influenza pandemic which happened a century ago. What are the new signs and symptoms? Will the current vaccines be able to fight the new strain? And what you must do to survive the deadly second wave which is causing more fatality ever? On such issues, India's leading expert, Dr Neeraj Nischal, Professor of Medicine at All India Institute of Medical Science (AIIMS), Delhi speaks with BW Businessworld’s Manish Kumar Jha. AIIMS professor sights that owing to the varied presentation of this disease, it wouldn't be incorrect to say that "any symptom could be a symptom of Covid-19". So don't let your guard off.

Read More

Sourav Ganguly likely to be discharged from hospital on Wednesday

Sourav Ganguly likely to be discharged from hospital on Wednesday

Read More

Study uncovers blood vessel damage, inflammation in COVID-19 patients' brains

Study uncovers blood vessel damage, inflammation in COVID-19 patients' brains

Read More

Sustained cellular immune dysregulation in individuals recovering from COVID-19: Study

Sustained cellular immune dysregulation in individuals recovering from COVID-19: Study

Read More

Study focuses on identification of SARS-CoV-2 virus features causing COVID-19 using primate model

Study focuses on identification of SARS-CoV-2 virus features causing COVID-19 using primate model

Read More

CPCB to deploy 50 teams in Delhi, NCR for strict vigil to curb pollution

CPCB to deploy 50 teams in Delhi, NCR for strict vigil to curb pollution

Read More

Study focuses on neurological consequences of COVID-19

Study focuses on neurological consequences of COVID-19

Read More

New Australian software tracks COVID-19 mutations that threaten vaccine efficacy

New Australian software tracks COVID-19 mutations that threaten vaccine efficacy

Read More